FDA Enforcement
Class II
Terminated
Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions
Recall: Z-2791-2016
·
Reported September 21, 2016
Enforcement
- Recall Number
- Z-2791-2016
- Event ID
- 74727
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Stryker Howmedica Osteonics Corp.
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Report Date
- September 21, 2016
- Initiation Date
- June 30, 2016
- Classification Date
- September 13, 2016
- Termination Date
- June 21, 2017
- Address
- 325 Corporate Dr, N/A, Mahwah, NJ, 07430-2006, United States
Description
Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions
Reason
Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field.
Code Info
Catalog number 18220930S and Lot Code K836729
Distribution
US distribution to state of: CA.
Quantity
1 unit in total